Anaplastic Oligodendroglioma and Anaplastic Oligoastrocytoma (MSK, Neuro Oncol 2017)

Summary

Anaplastic Oligodendroglioma and Anaplastic Oligoastrocytoma (MSK, Neuro Oncol 2017) is a study catalogued by cBioPortal DataHub under the cancer-type code difg. EvidenceHelix groups it with brain and nervous system studies.

Study description

IMPACT sequencing of 22 Anaplastic Oligodendroglioma and Anaplastic Oligoastrocytomas.

Text as published in the source's study metadata.

Citation & PubMed

Thomas et al. Neuro Oncol 2017

Linked PubMed records: PMID 28472509

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

odg_msk_2017

Short name

Glioma MSK (Neuro Oncol 2017)

Source cancer-type code

difg

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Thomas et al. Neuro Oncol 2017

• PubMed record 28472509 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Glioma (MSK, Clin Cancer Res 2019)

  Targeted sequencing on MSK-IMPACT and FMI Panels of 1004 samples (837 with matched normals) from 923 glioma patients.

  Brain and nervous systemMSK studiesSource code difgPubMed 1

• Glioma (MSK, Nature 2019)

  Targeted Sequencing of CSF samples (91 samples with 86 matched normals) from 42 glioma patients.

  Brain and nervous systemMSK studiesSource code difgPubMed 1

• IDH-mutated Diffuse Glioma (MSK, Clin Cancer Res 2024)

  Targeted sequencing of 73 IDH-mutated low-grade gliomas and their matched normal pairs via MSK-IMPACT. The data is available on Synapse (https://www.synapse.org/#!Synapse:syn52658621/wiki/624065).

  Brain and nervous systemMSK studiesSource code difgPubMed 1

• Brain Lower Grade Glioma (TCGA, Firehose Legacy)

  TCGA Brain Lower Grade Glioma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/LGG/20160128/). Previously known as TCGA Provisional.

  Brain and nervous systemTCGA Firehose LegacySource code difg

• Brain Lower Grade Glioma (TCGA, PanCancer Atlas)

  Brain Lower Grade Glioma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pancanceratlas…

  Brain and nervous systemTCGA PanCancer AtlasSource code difgPubMed 12

• Brain Tumor PDXs (Mayo Clinic, Clin Cancer Res 2020)

  WES on a total of 106 PDXs and 80 PDXs have the matched germline (blood) samples sequenced. A total of 66 PDXs have RNASeq available

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 1

• Diffuse Glioma (GLASS Consortium, Nature 2019)

  Whole genome or whole exome sequencing analysis of temporally separated diffuse glioma tumor/normal pairs from 222 adult patients.

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 1

• Diffuse Glioma (GLASS Consortium)

  Whole genome or whole exome sequencing analysis of temporally separated diffuse glioma tumor/normal pairs from 329 adult patients. The data provided is based on the May 31, 2022 version and can be accessed at Synapse…

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 2

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.